Heparin and protamine use in peripheral vascular surgery: A comparison between surgeons of the Society for Vascular Surgery and the European Society for Vascular Surgery
dc.contributor.author | Wakefield, Thomas W. | en_US |
dc.contributor.author | Lindblad, Bengt | en_US |
dc.contributor.author | Stanley, Timothy J. | en_US |
dc.contributor.author | Nichol, Brad J. | en_US |
dc.contributor.author | Stanley, James C. | en_US |
dc.contributor.author | Bergqvist, David | en_US |
dc.contributor.author | Greenfield, Lazar J. | en_US |
dc.contributor.author | Bergentz, Sven-Erik | en_US |
dc.date.accessioned | 2006-04-10T18:17:37Z | |
dc.date.available | 2006-04-10T18:17:37Z | |
dc.date.issued | 1994-03 | en_US |
dc.identifier.citation | Wakefield, Thomas W., Lindblad, Bengt, Stanley, Timothy J., Nichol, Brad J., Stanley, James C., Bergqvist, David, Greenfield, Lazar J., Bergentz, Sven-Erik (1994/03)."Heparin and protamine use in peripheral vascular surgery: A comparison between surgeons of the Society for Vascular Surgery and the European Society for Vascular Surgery." European Journal of Vascular Surgery 8(2): 193-198. <http://hdl.handle.net/2027.42/31719> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B7RMK-4FRD23W-4D/2/6f7d8286a72830a8743206d2ec5ad123 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/31719 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8181615&dopt=citation | en_US |
dc.description.abstract | It was the intent of this study to document, in general, the patterns and complications of heparin and protamine usage during carotid endarterectomy, aortic and femoral-popliteal-tibial reconstructions for occlusive disease, elective and emergent abdominal aortic aneurysmectomy, thromboembolectomy, and dialysis arteriovenous (AV) fistula placement by surgeons from North America and Europe. All vascular surgeons from the Society for Vascular Surgery (SVS) and the European Society for Vascular Surgery (ESVS) were surveyed by a voluntary, self-reported questionnaire. Six hundred and forty-six completed questionnaires (284 from SVS and 362 from ESVS), representing a 62% response rate, were returned for evaluation. Systemic and regional administration of heparin was common during vascular procedures performed by both SVS and ESVS surgeons. Use of protamine to reverse heparin anticoagulation varied among SVS and ESVS surgeons, respectively, during: carotid endarterectomy (54% vs. 26%, p p p p < 0.001). Adverse reactions to protamine among the 25 219 and 12 902 cases reported from SVS and ESVS surgeons, respectively, included: hypotension (1209 and 495 cases), pulmonary artery hypertension (65 and eight cases), anaphylaxis (52 and 10 cases), and death (seven and two cases). These adverse responses accounted for 5.3% and 4.0% of the SVS and ESVS cases, respectively. Although this study is subject to the known limitations of a retrospective survey, it is clear that heparin use is common. Protamine reversal of heparin anticoagulation is more common in North America. Severe reactions to protamine occur often enough to support the tenet that a safer compound is needed for heparin anticoagulation reversal. | en_US |
dc.format.extent | 567756 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Heparin and protamine use in peripheral vascular surgery: A comparison between surgeons of the Society for Vascular Surgery and the European Society for Vascular Surgery | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Surgery and Anesthesiology | en_US |
dc.subject.hlbsecondlevel | Radiology | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Section of Vascular Surgery, Department of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan, U.S.A. | en_US |
dc.contributor.affiliationum | Section of Vascular Surgery, Department of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan, U.S.A. | en_US |
dc.contributor.affiliationum | Section of Vascular Surgery, Department of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan, U.S.A. | en_US |
dc.contributor.affiliationum | Section of Vascular Surgery, Department of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan, U.S.A. | en_US |
dc.contributor.affiliationum | Section of Vascular Surgery, Department of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan, U.S.A. | en_US |
dc.contributor.affiliationother | Department of Surgery, Malmo General Hospital, Malmo, Sweden | en_US |
dc.contributor.affiliationother | Department of Surgery, Malmo General Hospital, Malmo, Sweden | en_US |
dc.contributor.affiliationother | Department of Surgery, Malmo General Hospital, Malmo, Sweden | en_US |
dc.identifier.pmid | 8181615 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/31719/1/0000655.pdf | en_US |
dc.identifier.source | European Journal of Vascular Surgery | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.